component-social-facebook_share_api-v2-01
      22
      Monday
      48 / 33
      Tuesday
      50 / 27
      Wednesday
      49 / 34

      Missouri share of Amgen settlement is $603,493

      Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp
      Missouri Attorney General Chris Koster says more than $600,000 has been recovered for the Missouri Medicaid program as part of a national settlement against the drug-maker Amgen Inc.

      Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp. Missouri was among several states that accused Amgen of a scheme aimed at inducing nursing home professionals to dispense Aranesp over competing drugs. Missouri's share is $603,493.

      Aranesp is one of Amgen's biggest-selling drugs, though sales have fallen sharply since 2007 because of a series of safety problems and restrictions on its use.

      In December, Amgen agreed to pay $762 million to resolve federal litigation accusing it of marketing Aranesp for unapproved uses.

      FOLLOW US ON TWITTER